Wolfgang Zauner

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Intercell Ag, Valneva Austria Gmbh, Affiris Ag. Active years: 1999-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang Zauner. Retrieved from https://idiyas.com/inventor/wolfgang-zauner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 40.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 6.8

ph-index = 5

Forward Citations = 45(Granted Patents)

Company Filing History:

Boehringer Ingelheim International Gmbh

patents

Years Active: 1999-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11065273 - Treatment and prevention of alzheimer's disease (AD) (2021-07-20),

2. 8900564 - Vaccine composition comprising an antigen and a peptide having adjuvant properties (2014-12-02),

3. 8715688 - Method for identification, isolation and production of antigens to a specific pathogen (2014-05-06),

4. 8361476 - Vaccine composition comprising an antigen and a peptide having adjuvant properties (2013-01-29),

5. 8323660 - Method for identification, isolation and production of antigens to a specific pathogen (2012-12-04),

6. 7968297 - Method for identification, isolation and production of antigens to a specific pathogen (2011-06-28),

7. 7771728 - Method for identification, isolation and production of antigens to a specific pathogen (2010-08-10),

8. 7658928 - Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide (2010-02-09),

9. 7378234 - Method for isolating hepatitis C virus peptides (2008-05-27),

10. 5965404 - Method for introducing nucleic acids into higher eukaryotic cells (1999-10-12),

Title: Innovations by Wolfgang Zauner: A Pioneer in Alzheimer's Disease Treatment and Vaccine Development

Introduction: Wolfgang Zauner, an accomplished inventor based in Vienna, Austria, has made significant contributions to the fields of medicine and biotechnology. With a portfolio of 10 patents, Zauner has focused primarily on the treatment and prevention of Alzheimer's disease and the development of innovative vaccine compositions. His groundbreaking work showcases his dedication to advancing healthcare solutions.

Latest Patents: Among Wolfgang Zauner's notable recent inventions is a treatment for Alzheimer's disease (AD), which discloses the use of an aluminum salt for preventing dementias associated with β-amyloid deposition. This novel approach targets one of the most pressing issues in neurology today. Additionally, he has developed a vaccine composition that comprises at least one antigen and a peptide with adjuvant properties. This peptide includes a specific amino acid sequence designed to enhance a patient's adaptive immune response to antigens. The strategic design of these inventions positions them as valuable contributions to advancing medical science.

Career Highlights: Throughout his career, Wolfgang Zauner has collaborated with prominent companies in the life sciences sector. Notable among these are Intercell AG and Valneva Austria GmbH, where he has employed his expertise to develop innovative therapies aimed at improving public health.

Collaborations: In his journey as an inventor, Zauner has worked alongside skilled colleagues, including Eszter Nagy and Michael Buschle. Their combined efforts have enhanced the potential impact of his research and have contributed to breakthroughs in their respective fields.

Conclusion: Wolfgang Zauner stands out as a prominent inventor whose work has significantly influenced the treatment of Alzheimer's disease and vaccine development. His prolific patent portfolio underscores his commitment to innovation in healthcare. As research continues to evolve, Zauner’s contributions are likely to pave the way for new medical advancements that will benefit countless individuals worldwide.

Profile summary based on public USPTO records.